| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.63 | 0.02 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |